Cramer-Gesundheits-Consulting: PR successes

PR successes

Jenapharm

Jenapharm

Right off the bat to market leadership position of Valette

Sector:
Research-based pharmaceutical industry

Client:
Jenapharm, Jena (now a subsidiary of Schering AG)

Communication task:
Product PR for the innovative ovulation inhibitor Valette, as from market launch

Target groups:
Gynaecologists
Young women
trade and lay media

Implementation and successes:
Rapid market penetration, mainly through media campaigns accompanied by intensive communication of the USP of Valette to medical specialists and consumers: also improves greasy skin and acne as well as greasy hair. An information centre staffed by physicians helps young women to overcome the hurdle of their first visit to a gynaecologist. Valette shortly becomes the market leader.

Continuative links:
www.jenapharm.de

Back to the overview

Contact

Cramer PR im Gesundheits-
wesen und Consultant GmbH
Rathausplatz 12-14
65760 Eschborn
Tel: +49 (0)6196 - 77 66 - 0
Fax: +49 (0)6196 - 77 66 - 216
Contact

© 2008 CGC Cramer-Gesundheits-Consulting GmbH Website credits Sitemap Data protection